What is refeeding syndrome? Refeeding syndrome can be defined as the potentially fatal shifts in fluids and electrolytes that may occur in malnourished patients. Acute liver failure (ALF) is defined as "the rapid development of hepatocellular dysfunction, specifically coagulopathy and mental status changes. Defintions Signs and Symptoms Physical/Medical Complications Definition. Anorexia nervosa is characterized by significant weight loss resulting from a restriction in. Depending on the severity of the hypophosphatemia, the patient may complain of muscle weakness and. Hypophosphatemia Clinical Presentation: History, Physical, Causes. Lapointe JY, Tessier J, Paquette Y, Wallendorff B, Coady MJ, Pichette V. NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium- phosphate cotransporter. N Engl J Med. 3. 47: 9. Jones A, Tzenova J, Frappier D, et al. Hereditary hypophosphatemic rickets with hypercalciuria is not caused by mutations in the Na/Pi cotransporter NPT2 gene. J Am Soc Nephrol. Segawa H, Onitsuka A, Kuwahata M, Hanabusa E, Furutani J, Kaneko I, et al. Type IIc sodium- dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol. Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption. Pflugers Arch. 4. Collins JF, Bal L, Ghishan FK. The SLC2. 0 family of protiens: dual functions as sodium- phosphate cotransporters and viral receptors. Pflugers Arch. 4. Virkki LV, Biber J, Murer H, Forster IC. Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol. F6. 43- 6. 54. Shaikh A, Berndt T, Kumar R. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr Nephrol. 2. Systemic Control of Bone Homeostasis by FGF2. Signaling. Curr Mol Biol Rep. Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD. Pathogenic role of Fgf. Hyp mice. Am J Physiol Endocrinol Metab. E3. 8- 4. 9. Mirams M, Robinson BG, Mason RS, Nelson AE. Physical Dangers and Effects of an Eating Disorder. There are many men and women suffering with all types of Eating Disorders that do not appear in any specific. Bone as a source of FGF2. Razzaque MS. FGF2. Klotho an essential player? Am J Physiol Renal Physiol. F7. 0- 4. 76. FGF- 2. FRP- 4 in chronic kidney disease and post- renal transplantation. Nephron Physiol. 1. Nishida Y, Taketani Y, Yamanaka- Okumura H, Imamura F, Taniguchi A, Sato T. Acute effect of oral phosphate loading on serum fibroblast growth factor 2. Liamis G, Milionis HJ, Elisaf M. Medication- induced hypophosphatemia: a review. Disorders of the renal proximal tubule. Nephron Physiol. 1. Sirac C, Bridoux F, Essig M, Devuyst O, Touchard G, Cogn. Toward understanding renal Fanconi syndrome: step by step advances through experimental models. Contrib Nephrol. Schwartz A, Brotfain E, Koyfman L, Kutz R, Gruenbaum SE, Klein M, et al. Association between Hypophosphatemia and Cardiac Arrhythmias in the Early Stage of Sepsis: Could Phosphorus Replacement Treatment Reduce the Incidence of Arrhythmias? Electrolyte Blood Press. Hypophosphatemia is a common complication in severely disabled individuals with neurological disorders and is caused by infection, refeeding and Fanconi syndrome. Dec 1. 8. Hypophosphatemia: an evidence- based problem- solving approach to clinical cases. Iran J Kidney Dis. Schubert L, De. Luca HF. Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys. Aug 1. 5. 5. 00(2): 1. O'Connor LR, Wheeler WS, Bethune JE. Effect of hypophosphatemia on myocardial performance in man. N Engl J Med. 1. 97. Oct 2. 7. 2. 97(1. Jaureguiberry G, Carpenter TO, Forman S, J. A novel missense mutation in SLC3. A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 1. Na. Pi- IIc. Am J Physiol Renal Physiol. F3. 71- 3. 79. PHEX gene and hypophosphatemia. Quarles LD, Drezner MK. Pathophysiology of X- linked hypophosphatemia, tumor- induced osteomalacia, and autosomal dominant hypophosphatemia: a per. PHEXing problem. J Clin Endocrinol Metab. Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA. Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf). Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE. FGF- 2. 3 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 1. Kaur U, Chakrabarti SS, Gambhir IS. Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern. Curr Drug Saf. 2. Apr 2. 6. Kreisl TN, Kimn L, Moore K, Duic P, Royce C, Stroud I, et al. Phase II trial of single- agent Bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurent glioblastoma. J Clin Oncol. Effricacy of RAD0. LAR in advanced low- to intermediate- grade neuroendocrine tumors: results of a phase II study. J Clin Oncol. 2. 6: 4. Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med. 2. 00. May 1. 1. 3. 54(1. Joensuu H, Reichardt P. Imatinib and altered bone and mineral metabolism. N Engl J Med. 2. 00. Aug 1. 0. 3. 55(6): 6. Gollob JA, Rathmell WK, Richmond TM, Marino CB, Miller EK, Grigson G, et al. Phase II trial of sorafenib plus interferon alfa- 2b as first- or second- line therapy in patients wtih metastatic renal cell cancer. J Clin Oncol. 2. 5: 3. Micetich KC, Futscher B, Koch D, Fisher RI, Erickson LC. Phase I study of streptozocin- and carmustine- sequenced administration in patients with advanced cancer. J Natl Cancer Inst. Ifosfamide- induced nephrotoxicity in 5. Late Effects Surveillance System. Pediatr Blood Cancer. Anticancer drug- induced kidney disorders. Tumor- induced osteomalacia. Rev Endocr Metab Disord. Most people with dumping syndrome develop signs and symptoms, such as abdominal cramps and diarrhea, 10 to 30 minutes after eating. Other people have symptoms one to. Laaban JP, Waked M, Laromiguiere M, Vuong TK, Rochemaure J. Hypophosphatemia complicating management of acute severe asthma. Ann Intern Med. 1. Paleologos M, Stone E, Braude S. Persistent, progressive hypophosphataemia after voluntary hyperventilation. Clin Sci (Lond). 9. Baia LC, Heilberg IP, Navis G, de Borst MH; NIGRAM investigators. Phosphate and FGF- 2. Nat Rev Nephrol. 1. Basquerizo A, Anselmo D, Shackleton C, et al. Phosphorus as an early predictive factor in patients with acute liver failure. Transplantation. 7. Chung PY, Sitrin MD, Te HS. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transplantation. Cohen J, Kogan A, Sahar G, et al. Hypophosphatemia following open heart surgery: incidence and consequences. Eur J Cardiothorac Surg. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Jul- Aug. 1. 7(7- 8): 6. Dickerson RN, Gervasio JM, Sherman JJ, et al. A comparison of renal phosphorus regulation in thermally injured and multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr. May- Jun. 2. 5(3): 1. Di. Meglio LA, Econs MJ. Hypophosphatemic rickets. Rev Endocr Metab Disord. Di. Meglio LA, White KE, Econs MJ. Disorders of phosphate metabolism. Endocrinol Metab Clin North Am. Duerksen DR, Papineau N. Electrolyte abnormalities in patients with chronic renal failure receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. Mar- Apr. 2. 2(2): 1. New insights into the pathogenesis of inherited phosphate wasting disorders. Faintuch J, Soriano FG, Ladeira JP, et al. Refeeding procedures after 4. Gannage MH, Abikaram G, Nasr F, Awada H. Osteomalacia secondary to celiac disease, primary hyperparathyroidism, and Graves'' disease. Am J Med Sci. 3. 15(2): 1. Green J, Debby H, Lederer E, et al. Evidence for a PTH- independent humoral mechanism in post- transplant hypophosphatemia and phosphaturia. Guy JM, Stewart MF, Olukoga A, et al. Hypophosphataemia in general practice patients. Ann Clin Biochem. Pt 1): 3. 7- 4. 2. Hypophosphataemia in anorexia nervosa. Postgrad Med J. 7. Haglin L, Burman LA, Nilsson M. High prevalence of hypophosphataemia amongst patients with infectious diseases. A retrospective study. J Intern Med. 2. 46(1): 4. Hardy DC, Murphy WA, Siegel BA, et al. X- linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Hicks W, Hardy G. Phosphate supplementation for hypophosphataemia and parenteral nutrition. Curr Opin Clin Nutr Metab Care. Julian BA, Quarles LD, Niemann KM. Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis. 1. Kagansky N, Levy S, Koren- Morag N. Hypophosphataemia in old patients is associated with the refeeding syndrome and reduced survival. J Intern Med. 2. 57: 4. Kalaitzidis R, Tsimihodimos V, Bairaktari E, et al. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis. Refeeding syndrome and hypophosphatemia. J Intensive Care Med. Kohn MR, Golden NH, Shenker IR. Cardiac arrest and delirium: presentations of the refeeding syndrome in severely malnourished adolescents with anorexia nervosa. J Adolesc Health. Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm. Tumor- induced osteomalacia and the regulation of phosphate homeostasis. Lee JH, Choi SJ, Lee JH, et al. Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. Novel Na. Pi- 2c mutations that cause mistargeting of Na. Pi- 2c protien and uncoupling of Na- Pi cause HHRH. Am J Physiol Renal Physiol. F3. 69- 3. 70. Liu YL, Lin HH, Yu CC, Kuo HL, Yang YF, Chou CY. A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients. Marinella MA. Refeeding syndrome and hypophosphatemia. J Intensive Care Med. Marshall MR, Golper TA, Shaver MJ, et al. Sustained low- efficiency dialysis for critically ill patients requiring renal replacement therapy. Melvin JD, Watts RG. Severe hypophosphatemia: a rare cause of intravascular hemolysis. Am J Hematol. 6. 9(3): 2. Milionis HJ, Alexandrides GE, Liberopoulos E, et al. Hypomagnesemia and concurrent acid- base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail. Miller DW, Slovis CM. Hypophosphatemia in the emergency department therapeutics. Am J Emerg Med. 1. Morris AA, Baudouin SV, Snow MH. Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors. Ornstein RM, Golden NH, Jacobson MS, Shenker IR. Hypophosphatemia during nutritional rehabilitation in anorexia nervosa: implications for refeeding and monitoring. J Adolesc Health. Peacock M, Bilezekian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long- term normocalcemia in patients with primary hyperparathyroidism. Medical Definition of Nasogastric tube. Nasogastric tube: A tube that is passed through the nose and down through the nasopharynx and esophagus into the stomach. Abbreviated NG tube. It is a flexible tube made of rubber or plastic, and it has bidirectional potential. It can be used to remove the contents of the stomach, including air, to decompress the stomach, or to remove small solid objects and fluid, such as poison, from the stomach. An NG tube can also be used to put substances into the stomach, and so it may be used to place nutrients directly into the stomach when a patient cannot take food or drink by mouth. Last Editorial Review: 5/1. Back to Med. Terms online medical dictionary A- Z List. Need help identifying pills and medications? Use the pill finder tool on Rx.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
May 2017
Categories |